SUGACIP Trademark

Trademark Overview

On Thursday, April 6, 2017, a trademark application was filed for SUGACIP with the United States Patent and Trademark Office. The USPTO has given the SUGACIP trademark a serial number of 87401532. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2019. This trademark is owned by CIPLA LIMITED. The SUGACIP trademark is filed in the Pharmaceutical Products category with the following description:

Medical and Pharmaceutical preparations for reversal of neuromuscular blockade produced by rocuronium bromide and vecuronium bromide
sugacip

General Information

Serial Number87401532
Word MarkSUGACIP
Filing DateThursday, April 6, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2018

Trademark Statements

Goods and ServicesMedical and Pharmaceutical preparations for reversal of neuromuscular blockade produced by rocuronium bromide and vecuronium bromide

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCIPLA LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN
Party NameCIPLA LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN

Trademark Events

Event DateEvent Description
Monday, March 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 31, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 5, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 26, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 28, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 28, 2018FINAL REFUSAL E-MAILED
Wednesday, February 28, 2018FINAL REFUSAL WRITTEN
Tuesday, February 13, 2018ASSIGNED TO EXAMINER
Friday, January 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 11, 2018ASSIGNED TO LIE
Friday, December 22, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2017NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2017ASSIGNED TO EXAMINER
Thursday, April 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 10, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

sugacip bromide produced rocuronium blockade vecuronium neuromuscular pharmaceutical preparations reversal medical